IV methylprednisolone

DRUG3 trials

Sponsors

Biogen, Fred Lublin, Göteborg University

Conditions

Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingOphthalmopathy, Thyroid-Associated

Phase 3

Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks

TerminatedNCT00418145

Fred LublinMultiple Sclerosis

Start: 2003-09-30End: 2013-10-31Updated: 2017-05-18

Phase 4

AVONEX® Combination Trial - ACT

CompletedNCT00112034

BiogenMultiple Sclerosis, Relapsing-Remitting

Start: 2003-06-30End: 2007-05-31Target: 350Updated: 2008-05-09

Rituximab (RTX) Therapy in Patients With Active TAO

CompletedNCT02378298

Göteborg UniversityOphthalmopathy, Thyroid-Associated

Start: 2011-12-31End: 2020-02-01Updated: 2025-03-26